Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.

Abstract

The endocannabinoid system consists of two cannabinoid receptors (CB1 and CB2), endogenous ligands (endocannabinoids), and the enzymes involved in the metabolism of the endocannabinoids, including fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL). In the present study, virtual screening of MGL inhibitors was performed by utilizing a comparative model of the human MGL enzyme. All hit molecules were tested for their potential MGL inhibitory activity, but no compounds were found capable of inhibiting MGL-like enzymatic activity in rat cerebellar membranes. However, these compounds were also tested for their potential FAAH inhibitory activity and five compounds (2-6) inhibiting FAAH were found with IC50 values between 4 and 44 microM. In addition, the hit molecules from the virtual screening of CB2 receptor ligands (reported previously in Salo et al. J. Med. Chem. 2005, 48, 7166) were also tested in our FAAH assay, and four active compounds (7-10) were found with IC50 values between 0.52 and 22 microM. Additionally, compound 7 inhibited MGL-like enzymatic activity with an IC50 value of 31 microM.

Statistics

05020072008200920102011201220132014201520162017
Citations per Year

83 Citations

Semantic Scholar estimates that this publication has 83 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Saario2006FattyAA, title={Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.}, author={Susanna M Saario and Antti Poso and Risto Juvonen and Tomi J{\"a}rvinen and Outi M H Salo-Ahen}, journal={Journal of medicinal chemistry}, year={2006}, volume={49 15}, pages={4650-6} }